Literature DB >> 18478010

Synergistic signaling from extracellular matrix-growth factor complexes.

Richard A F Clark1.   

Abstract

Investigations on extracellular matrix (ECM) and growth factor (GF) complexes have revealed an underappreciated phenomenon: they can either negate GF activity or generate synergistic signals for cell function, in particular mitogenesis. ECM and pericellular matrix molecules were first recognized to complex with GFs and regulate GF activity by the seminal observations that basic fibroblast growth factor (bFGF or FGF-2) required binding to a cell-surface heparin sulfate proteoglycan and to its authentic cell-surface receptor for biological activity (Klagsbrun and Baird, 1991; Yayon et al., 1991). Subsequently, numerous ECM-GF interactions that modulate GF activity were discovered; we have reviewed many of these findings (Macri et al., 2007).

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18478010     DOI: 10.1038/jid.2008.75

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  18 in total

1.  Full-thickness skin wound healing using human placenta-derived extracellular matrix containing bioactive molecules.

Authors:  Ji Suk Choi; Jae Dong Kim; Hyun Soo Yoon; Yong Woo Cho
Journal:  Tissue Eng Part A       Date:  2012-09-24       Impact factor: 3.845

2.  Human adipose-derived stromal cells accelerate diabetic wound healing: impact of cell formulation and delivery.

Authors:  Peter J Amos; Sahil K Kapur; Peter C Stapor; Hulan Shang; Stefan Bekiranov; Moshe Khurgel; George T Rodeheaver; Shayn M Peirce; Adam J Katz
Journal:  Tissue Eng Part A       Date:  2010-05       Impact factor: 3.845

Review 3.  Growth factor-eluting technologies for bone tissue engineering.

Authors:  Ethan Nyberg; Christina Holmes; Timothy Witham; Warren L Grayson
Journal:  Drug Deliv Transl Res       Date:  2016-04       Impact factor: 4.617

4.  Characterization of the growth modulatory activities of osteoblast conditioned media on cord blood progenitor cells.

Authors:  Ahmad Abu-Khader; Roya Pasha; Gwendoline C D Ward; Gavin Boisjoli; Nicolas Pineault
Journal:  Cytotechnology       Date:  2016-10-18       Impact factor: 2.058

Review 5.  The fibrotic tumor stroma.

Authors:  Mitsuo Yamauchi; Thomas H Barker; Don L Gibbons; Jonathan M Kurie
Journal:  J Clin Invest       Date:  2018-01-02       Impact factor: 14.808

6.  Fibronectin growth factor-binding domains are required for fibroblast survival.

Authors:  Fubao Lin; Xiang-Dong Ren; Zhi Pan; Lauren Macri; Wei-Xing Zong; Marcia G Tonnesen; Miriam Rafailovich; Dafna Bar-Sagi; Richard A F Clark
Journal:  J Invest Dermatol       Date:  2010-09-02       Impact factor: 8.551

Review 7.  Diabetic lower extremity wounds: the rationale for growth factors-based infiltration treatment.

Authors:  Jorge Berlanga-Acosta
Journal:  Int Wound J       Date:  2011-09-13       Impact factor: 3.315

8.  Inkjet-based biopatterning of bone morphogenetic protein-2 to spatially control calvarial bone formation.

Authors:  Gregory M Cooper; Eric D Miller; Gary E Decesare; Arvydas Usas; Emily L Lensie; Michael R Bykowski; Johnny Huard; Lee E Weiss; Joseph E Losee; Phil G Campbell
Journal:  Tissue Eng Part A       Date:  2010-05       Impact factor: 3.845

9.  Odontogenic induction of dental stem cells by extracellular matrix-inspired three-dimensional scaffold.

Authors:  Sriram Ravindran; Youbin Zhang; Chun-Chieh Huang; Anne George
Journal:  Tissue Eng Part A       Date:  2013-08-21       Impact factor: 3.845

Review 10.  Update on therapeutic vascularization strategies.

Authors:  Edward A Phelps; Andres J Garcia
Journal:  Regen Med       Date:  2009-01       Impact factor: 3.806

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.